(Q33456658)
Statements
Phase I clinical and pharmacokinetic study of hexamethylene bisacetamide (NSC 95580) administered as a five-day continuous infusion (English)
Egorin MJ
Sigman LM
Van Echo DA
Forrest A
Whitacre MY
scientific article